Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome. Circulation. 2004;109:1826 33. S7.9.1.1-17. Bai R, Napolitano C, Bloise R, et al. Yield of genetic screening in inherited cardiac channelopathies: how to prioritize access to genetic testing. Circ Arrhythm Electrophysiol. 2009;2:6 15. S7.9.1.1-18. Costa J, Lopes CM, Barsheshet A, et al. Combined assessment of sex- and mutation-specific information for risk stratification in type 1 long QT syndrome. Heart Rhythm. 2012;9:892 8. S7.9.1.1-19. Kim JA, Lopes CM, Moss AJ, et al. Trigger-specific risk factors and response to therapy in long QT syndrome type 2. Heart Rhythm. 2010;7:1797 805. S7.9.1.1-20. Migdalovich D, Moss AJ, Lopes CM, et al. Mutation and gender- specific risk in type 2 long QT syndrome: implications for risk stratification for life-threatening cardiac events in patients with long QT syndrome. Heart Rhythm. 2011;8:1537 43. S7.9.1.1-21. Tester DJ, Will ML, Haglund CM, et al. Effect of clinical phenotype on yield of long QT syndrome genetic testing. J Am Coll Cardiol. 2006;47:764 8. S7.9.1.1-22. Adler A, van der Werf C, Postema PG, et al. The phenomenon of QT stunning : The abnormal QT prolongation provoked by standing persists even as the heart rate returns to normal in patients with long QT syndrome. Heart Rhythm. 2012;9:901 8. S7.9.1.1-23. Aziz PF, Wieand TS, Ganley J, et al. Genotype- and mutation site-specific QT adaptation during exercise, recovery, and pos- tural changes in children with long-QT syndrome. Circ Arrhythm Electrophysiol. 2011;4:867 73. S7.9.1.1-24. Chattha IS, Sy RW, Yee R, et al. Utility of the recovery electrocar- diogram after exercise: a novel indicator for the diagnosis and genotyping of long QT syndrome? Heart Rhythm. 2010;7:906 11. S7.9.1.1-25. Laksman ZW, Hamilton RM, Chockalingam P, et al. 